ClassID:

96898

C07K14/47 - page 13 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Recent Application in this class:
#3601
20120308528
2012-12-06

Methods and compositions for gene inactivation

#3602
20120302452
2012-11-29

COMPARATIVE LIGAND MAPPING FROM MHC CLASS I POSITIVE CELLS

#3603
20120301894
2012-11-29

LABELING AND DETECTION OF POST TRANSLATIONALLY MODIFIED PROTEINS

#3604
20120301871
2012-11-29

COMPARATIVE LIGAND MAPPING FROM MHC POSITIVE CELLS

#3605
20120301485
2012-11-29

Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof

#3606
20120301457
2012-11-29

LIPID COFACTORS FOR FACILITATING PROPOGATION OF PRPsc

#3607
20120301431
2012-11-29

Methods of treating a disease or condition associated with abnormal angiogenesis

#3608
20120301393
2012-11-29

MODIFIED UBIQUITIN PROTEINS HAVING A SPECIFIC BINDING ACTIVITY FOR THE EXTRADOMAIN B OF FIBRONECTIN

#3609
20120295851
2012-11-22

Peptides, compositions and uses thereof

#3610
20120294850
2012-11-22

Ganglioside epitopes for treating Guillain-Barre syndrome

#3611
20120294838
2012-11-22

Regulation of endogenous gene expression in cells using zinc finger proteins

#3612
20120288913
2012-11-15

NOVEL FUSION PARTNERS FOR THE PURPOSE OF CRYSTALLIZING G-PROTEIN COUPLED RECEPTORS

#3613
20120288536
2012-11-15

Stabilized STAT3 decoy oligonucleotides and uses therefor

#3614
20120288503
2012-11-15

Antibodies that bind polypeptides involved in the process of bone remodeling

#3615
20120288498
2012-11-15

POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN CANCER

#3616
20120288472
2012-11-15

REGULATION OF T CELL-MEDIATED IMMUNITY BY TRYPTOPHAN

#3617
20120283166
2012-11-08

PEPTIDE PRODRUGS

#3618
20120283127
2012-11-08

Diagnostic method for Alzheimer's disease

#3619
20120283126
2012-11-08

HUMAN FERTILITY TEST USING DPY19L2

#3620
20120283116
2012-11-08

Mutant Sodium Channel Nav1.7 and Methods Related Thereto

#3621
20120282626
2012-11-08

Selective incorporation of 5-hydroxytryptophan into proteins in mammalian cells

#3622
20120282290
2012-11-08

Mycobacterial vaccines

#3623
20120282256
2012-11-08

Chimeric receptors with 4-1BB stimulatory signaling domain

#3624
20120278909
2012-11-01

Compositions and methods for determining genetic polymorphisms in the TMEM216 gene

#3625
20120277143
2012-11-01

IL4/IL13 binding repeat proteins and uses

#3626
20120276551
2012-11-01

Methods predicting risk of an adverse clinical outcome

#3627
20120276529
2012-11-01

Mutated SUMO isoforms and uses thereof

#3628
20120272345
2012-10-25

DIAGNOSIS MARKER, DIAGNOSIS METHOD AND THERAPEUTIC AGENT FOR AMYOTROPHIC LATERAL SCLEROSIS, AND ANIMAL MODEL AND CELL MODEL DEVELOPING AMYOTROPHIC LATERAL SCLEROSIS

#3629
20120271041
2012-10-25

Production of glycoproteins with low N-glycolylneuraminic acid (NEU5GC) content

#3630
20120271032
2012-10-25

Preparation of a Therapeutic Composition

#3631
20120270800
2012-10-25

Bifunctional stapled polypeptides and uses thereof

#3632
20120270790
2012-10-25

Compositions and methods for the treatment of myocardial ischemia/reperfusion injury with Annexin A1 short peptide

#3633
20120269798
2012-10-25

Methods for identifying candidate modulators of NOTUM activity

#3634
20120264625
2012-10-18

COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF CERVICAL CANCER

#3635
20120263852
2012-10-18

WHEY PROTEIN CONCENTRATE, ITS PREPARATION AND ITS USE

#3636
20120263747
2012-10-18

Albumin-Fused Anti-Angiogenesis Peptides

#3637
20120260344
2012-10-11

Method and system of runtime analysis

#3638
20120258887
2012-10-11

CC2D2A gene mutations associated with joubert syndrome and diagnostic methods for identifying the same

#3639
20120258865
2012-10-11

Mirac proteins

#3640
20120258458
2012-10-11

INTERFERON-LIKE PROTEIN ZCYTO21

#3641
20120258091
2012-10-11

Genetic products differentially expressed in tumors and the use thereof

#3642
20120252877
2012-10-04

METHODS AND COMPOSITIONS FOR TREATMENT OF TUBEROUS SCLEROSIS COMPLEX

#3643
20120252717
2012-10-04

Conjugates of biologically active polypeptides having an increased in vivo half-life

#3644
20120251563
2012-10-04

MODULATION OF IMMUNE RESPONSE BY NON-PEPTIDE BINDING STRESS RESPONSE POLYPEPTIDES

#3645
20120251543
2012-10-04

METHODS AND COMPOSITIONS FOR MODULATING APOPTOSIS

#3646
20120251539
2012-10-04

Methods and compositions for the treatment of immune disorders

#3647
20120251510
2012-10-04

Agents for promoting tissue regeneration by recruiting bone marrow mesenchymal stem cells and/or pluripotent stem cells into blood

#3648
20120245216
2012-09-27

Compositions and methods for treatment of neuropathic pain

#3649
20120245093
2012-09-27

Neuronal viability factor and use thereof

#3650
20120244636
2012-09-27

INCORPORATION OF METHYL LYSINE INTO POLYPEPTIDES

#3651
20120244615
2012-09-27

Isolated A-type FHF N-terminal domain peptides and methods of use

#3652
20120244596
2012-09-27

Anticalins

#3653
20120244577
2012-09-27

Multivalent heteromultimer scaffold design and constructs

#3654
20120244209
2012-09-27

TUSC2 THERAPIES

#3655
20120237588
2012-09-20

METHODS OF IMPROVING CARDIAC FUNCTION AND ATTENUATING AND/OR PREVENTING CARDIAC REMODELING WITH HSP20

#3656
20120232012
2012-09-13

Compositions having antiangiogenic activity and uses thereof

#3657
20120232007
2012-09-13

Method for producing proteins in that lack detectable cross binding activity to antibodies against host cell antigens

#3658
20120231521
2012-09-13

Transducible polypeptides for modifying metabolism

#3659
20120231008
2012-09-13

Anti-C5a binding antibodies with high block activity

#3660
20120231006
2012-09-13

ANTI-ORAI1 ANTIGEN BINDING PROTEINS AND USES THEREOF

#3661
20120231002
2012-09-13

Treatment of vasculoproliferative conditions with Lrg1 anatgonists

#3662
20120230947
2012-09-13

BIOLOGICALLY ACTIVE PROTEINS HAVING INCREASED IN VIVO AND/OR IN VITRO STABILITY

#3663
20120220755
2012-08-30

ORGANIC CATION TRANSPORTER POLYPEPTIDES

#3664
20120220536
2012-08-30

Use of endostatin peptides for the treatment of fibrosis

#3665
20120220011
2012-08-30

UNSTRUCTURED RECOMBINANT POLYMERS AND USES THEREOF

#3666
20120220007
2012-08-30

PRODUCTION OF SECRETED BIOPRODUCTS FROM PHOTOSYNTHETIC MICROBES

#3667
20120219977
2012-08-30

Sequences, antibodies, methods and kits for detection and in vitro assay of periostin, in order to provide a diagnosis, follow-up or prognosis of diseases and biological phenomena involving periostin

#3668
20120219540
2012-08-30

COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES

#3669
20120219498
2012-08-30

Compositions and methods for inducing angiogenesis

#3670
20120214744
2012-08-23

Polypeptides and nucleic acids for treating ErbB2-dependent cancers

#3671
20120214737
2012-08-23

METHODS FOR PROTECTING DOPAMINERGIC NEURONS FROM STRESS AND PROMOTING PROLIFERATION AND DIFFERENTIATION OF OLIGODENDROCYTE PROGENITORS BY NRG-2

#3672
20120214730
2012-08-23

Method of using heparin binding motif for treating asthma

#3673
20120213809
2012-08-23

Vault complexes for cytokine delivery

#3674
20120208234
2012-08-16

Protein having affinity for immunoglobulin, and immunoglobulin-binding affinity ligand

#3675
20120207724
2012-08-16

Compositions for improving migration potential of stem cells

#3676
20120204281
2012-08-09

DRG11-responsive (dragon) polypeptides

#3677
20120204280
2012-08-09

DRG11-responsive (DRAGON) gene family

#3678
20120202749
2012-08-09

Methods of use of fragments of secreted frizzled related protein, sFRP

#3679
20120201873
2012-08-09

CONTROLLED RELEASE FORMULATIONS OF LIPOCALIN MUTEINS

#3680
20120201840
2012-08-09

EphA2 T cell epitopes and uses therefor

#3681
20120196761
2012-08-02

DIAGNOSIS OF IN SITU AND INVASIVE BREAST CANCER

#3682
20120195935
2012-08-02

MICROBUBBLE ASSISTED VIRAL DELIVERY

#3683
20120195829
2012-08-02

METHODS FOR IDENTIFYING TARGETING DOMAINS AND METHOD AND COMPOSITIONS COMPRISING THE SAME

#3684
20120190827
2012-07-26

Modified human plasma polypeptide or Fc scaffolds and their uses

#3685
20120190628
2012-07-26

GENES AND POLYPEPTIDES RELATING TO HUMAN COLON CANCERS

#3686
20120190609
2012-07-26

METHOD FOR PRODUCING A LIPID PARTICLE, THE LIPID PARTICLE ITSELF AND ITS USE

#3687
20120190576
2012-07-26

Glycan markers as measure of disease state of hepatic diseases

#3688
20120190107
2012-07-26

ENHANCED PROTEIN TRANSDUCTION

#3689
20120190039
2012-07-26

RAF DIMERS AND USES THEREOF

#3690
20120190017
2012-07-26

POLYMORPHISMS IN THE HUMAN GENE FOR THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1 (MRP-1) AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

#3691
20120183999
2012-07-19

USE OF MULTIPLE RECOMBINATION SITES WITH UNIQUE SPECIFICITY IN COMBINATIONAL CLONING

#3692
20120183973
2012-07-19

BIOMARKER COMPOSITION FOR DETECTING DIABETIC RETINOPATHY AND DIAGNOSTIC KIT THEREFOR

#3693
20120183598
2012-07-19

HLA-A2 TUMOR ASSOCIATED ANTIGEN PEPTIDES AND COMPOSITIONS

#3694
20120183552
2012-07-19

KIDNEY DISEASE TARGETS AND USES THEREOF

#3695
20120180151
2012-07-12

Genetic vasectomy by overexpression of PRML-EGFP fusion protein in spermatids

#3696
20120180150
2012-07-12

INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR-BINDING PROTEIN AND ITS NON-HUMAN TRANSGENIC MAMMALIAN ANIMALS

#3697
20120178901
2012-07-12

Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof

#3698
20120178792
2012-07-12

DRG11-responsive (DRAGON) gene family

#3699
20120178700
2012-07-12

PEPTIDOMIMETIC MACROCYCLES

#3700
20120177659
2012-07-12

Methods and compositions for treating and diagnosing diseases

#3701
20120172315
2012-07-05

Peptides used for treating cancers and, in particular, chronic lymphoid leukaemia

#3702
20120172285
2012-07-05

Methods and compositions for specific modulation of MCL-1

#3703
20120171779
2012-07-05

Method of detection using antibodies that specifically bind hedgehog-derived polypeptides

#3704
20120171205
2012-07-05

Galectin-immunoglobulin chimeric molecules

#3705
20120171204
2012-07-05

COMPOSITIONS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF IMMUNE DISORDERS

#3706
20120171122
2012-07-05

Loop-Variant Pdz Domains As Biotherapeutics, Diagnostics And Research Reagents

#3707
20120171117
2012-07-05

Radiofluorinated compounds and their preparation

#3708
20120167236
2012-06-28

Method of predicting a behavior of one or more drugs

#3709
20120164147
2012-06-28

Nucleic acids encoding TNFγ

#3710
20120164127
2012-06-28

Mirac proteins

#3711
20120164123
2012-06-28

Method for the treatment of pulmonary disease and method of producing proteins of use therein

#3712
20120157372
2012-06-21

Human milk peptides

#3713
20120156234
2012-06-21

Means for treating synucleinopathies

#3714
20120156175
2012-06-21

Composition for inducing migration of neural stem cells containing periostin as effective ingredient

#3715
20120149652
2012-06-14

Phosphorylated derivatives of a U1-70K peptide and their use in the treatment of autoimmune pathologies

#3716
20120149645
2012-06-14

COMPOSITIONS AND MODULATION OF MYOCYTE ENHANCER FACTOR 2 (MEF2)

#3717
20120149034
2012-06-14

Biomarker for psychiatric diseases including cognitive impairment and methods for detecting psychiatric diseases including cognitive impairment using the biomarkers

#3718
20120148606
2012-06-14

Chimeric toll-like receptor/MD-2 polypeptides and methods of use thereof

#3719
20120142890
2012-06-07

Biosynthetic Polypeptide Fusion Inhibitors

#3720
20120142611
2012-06-07

Repeat protein from collection of repeat proteins comprising repeat modules

#3721
20120142110
2012-06-07

Method of Genetically Altering and Producing Allergy Free Cats

#3722
20120142099
2012-06-07

NOVEL BAK BINDING PROTEIN, DNA ENCODING THE PROTEIN, AND METHODS OF USE THEREOF

#3723
20120142062
2012-06-07

Engineered cleavage half-domains

#3724
20120142022
2012-06-07

GLYCOSYLATED MAMMALIAN NGAL AND USE THEREOF

#3725
20120141983
2012-06-07

Quantitative Aggregation Sensors

#3726
20120141534
2012-06-07

Vault compositions for immunization against Chlamydia genital infection

#3727
20120141469
2012-06-07

CRIPTO ANTAGONISM OF ACTIVIN AND TGF-B SIGNALING

#3728
20120135408
2012-05-31

UNC-45A splice variants based cancer diagnostics and therapeutics

#3729
20120135031
2012-05-31

METHOD OF ENHANCING AN IMMUNE RESPONSE

#3730
20120135008
2012-05-31

Methods and compositions for targeting polyubiquitin

#3731
20120134997
2012-05-31

Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics

#3732
20120134991
2012-05-31

Polypeptides and methods for modulating D1-D2 dopamine receptor interaction and function

#3733
20120134925
2012-05-31

Application and uses of PRG4 and therapeutic modulation thereof

#3734
20120130044
2012-05-24

Stable analogs of peptide and polypeptide therapeutics

#3735
20120129776
2012-05-24

Peptide ligands for G-protein coupled receptors

#3736
20120129184
2012-05-24

SYSTEMIC CARNITINE DEFICIENCY GENE AND USES THEREOF

#3737
20120129161
2012-05-24

Methods for modulating embryonic stem cell differentiation

#3738
20120128627
2012-05-24

IL-17 HOMOLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF

#3739
20120128624
2012-05-24

Recombinant Human Albumin-Granulocyte Macrophage Colony Stimulating Factor Fusion Protein With Long-Lasting Biological Effects

#3740
20120124684
2012-05-17

COMPOSITIONS AND METHODS USING ALPHA BETA-CRYSTALLIN IN PROTECTING THE MYOCARDIUM FROM ISCHEMIA/REPERFUSION INJURY

#3741
20120122778
2012-05-17

Modified TGF-β superfamily protein

#3742
20120122762
2012-05-17

186 Human Secreted Proteins

#3743
20120122669
2012-05-17

Method of arraying ferritin

#3744
20120122156
2012-05-17

RECOMBINANT PROTEIN OF FIBROBLAST GROWTH FACTOR HAVING ADHESIVE ACTIVITY FOR STEM CELLS AND METHOD FOR CULTURING STEM CELLS USING THE SAME

#3745
20120122113
2012-05-17

Signature Of Secreted Protein Isoforms Specific To Ovarian Cancer

#3746
20120121602
2012-05-17

Proteins

#3747
20120121595
2012-05-17

FRAGMENT OF SECRETED HEAT SHOCK PROTEIN-90ALPHA (Hsp90ALPHA) AS VACCINES OR EPITOPE FOR MONOCLONAL ANTIBODY DRUGS OR TARGET FOR SMALL MOLECULE DRUGS AGAINST A RANGE OF SOLID HUMAN TUMORS

#3748
20120116061
2012-05-10

Method of arraying ferritin

#3749
20120115793
2012-05-10

PEPTIDOMIMETIC MACROCYCLES

#3750
20120115221
2012-05-10

SPARC-derived tumor rejection antigenic peptides and medicaments comprising the same

#3751
20120108657
2012-05-03

Compositions comprising polynucleotides encoding RDCVF1 or RDCVF2

#3752
20120108523
2012-05-03

Methods of increasing RDCVF 1 or RDCVF 2 polypeptides in retinal cells

#3753
20120107858
2012-05-03

CANCER DIAGNOSIS METHOD USING THE GLYCOSYLATION OF A GLYCOPROTEIN

#3754
20120107321
2012-05-03

Antibodies And Epitopes Specific To Misfolded Prion Protein

#3755
20120101045
2012-04-26

Transducible delivery of nucleic acids using modified dsRNA binding domains

#3756
20120101021
2012-04-26

COMPOSITIONS, FORMULATIONS AND METHODS OF TREATING PREECLAMPSIA-TYPE DISORDERS OF PREGNANCY

#3757
20120100553
2012-04-26

CHO/CERT cell lines

#3758
20120100173
2012-04-26

METHODS FOR PREPARING AND USING MULTICHAPERONE-ANTIGEN COMPLEXES

#3759
20120100166
2012-04-26

Ang-2 Binding Complexes and Uses Thereof

#3760
20120100146
2012-04-26

Nucleotide and amino acid sequences relating to respiratory diseases and obesity

#3761
20120095444
2012-04-19

Polynucleotides encoding a human TRIM-Cyp fusion polypeptide, compositions thereof, and methods of using same

#3762
20120094937
2012-04-19

MAMMALIAN CELL SURFACE ANTIGENS; RELATED REAGENTS

#3763
20120094299
2012-04-19

NUCLEOTIDE REPEAT EXPANSION-ASSOCIATED POLYPEPTIDES AND USES THEREOF

#3764
20120094297
2012-04-19

Method for producing protein

#3765
20120093873
2012-04-19

Molecular Interactions in Hematopoietic Cells

#3766
20120093844
2012-04-19

Antimicrobial peptides based on CMAP27

#3767
20120093822
2012-04-19

Polypeptides that inhibit dopamine D2 receptor-DISC1 interaction and methods of use thereof

#3768
20120093820
2012-04-19

Prostatitis-associated antigens and methods of use thereof

#3769
20120093798
2012-04-19

Methods for treatment of stroke or cerebrovascular accidents using an ETB receptor agonist

#3770
20120093734
2012-04-19

PROTEIN-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF COLORECTAL ADENOCARCINOMA

#3771
20120088287
2012-04-12

CRIPTO ANTAGONISM OF ACTIVIN AND TGF-B SIGNALING

#3772
20120087929
2012-04-12

VEGF antagonist formulations for intravitreal administration

#3773
20120087910
2012-04-12

SPARC ANGIOGENIC DOMAIN AND METHODS OF USE

#3774
20120087870
2012-04-12

NOVEL CAVIIDAE ALLERGENS AND USES THEREOF

#3775
20120087861
2012-04-12

Human anti-tau antibodies

#3776
20120083420
2012-04-05

COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES

#3777
20120083003
2012-04-05

PARKIN SUBSTRATE AND ASSAY

#3778
20120082684
2012-04-05

DIAGNOSIS AND TREATMENT OF CELL PROLIFERATION AND DIFFERENTIATION DISORDERS BASED ON THE FMN2 GENE

#3779
20120076826
2012-03-29

Recombinantly produced allergens

#3780
20120076789
2012-03-29

NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 121P1F1 USEFUL IN TREATMENT AND DETECTION OF CANCER

#3781
20120071704
2012-03-22

MITOCHONDRIAL LOCALIZATION OF MUC1

#3782
20120071415
2012-03-22

DOMINANT NEGATIVE MUTANTS OF SAM68 FOR USE IN THE TREATMENT OF SPINAL MUSCULAR ATROPHY (SMA)

#3783
20120071399
2012-03-22

Sulfation of Wnt pathway proteins

#3784
20120070854
2012-03-22

HNRNP A3 related peptides and use thereof for diagnosis of rheumatoid arthritis

#3785
20120070843
2012-03-22

DBC1, A NOVEL NATIVE INHIBITOR OF THE ANTI-AGING PROTEIN SIRT1

#3786
20120070834
2012-03-22

Screening methods for transfusion related acute lung injury

#3787
20120070826
2012-03-22

Lafora's disease gene

#3788
20120066775
2012-03-15

Antibodies that bind stresscopin peptides

#3789
20120065574
2012-03-15

Isoform Nell-1 peptide

#3790
20120065139
2012-03-15

GQ protein competitive inhibitory polypeptides, preparation methods and uses thereof

#3791
20120065125
2012-03-15

Methods and compositions for the treatment of cancer or other diseases

#3792
20120064626
2012-03-15

B7-H1 antibodies and method of use

#3793
20120064571
2012-03-15

ZCYTOR19 POLYNUCLEOTIDES, POLYPEPTIDES, ANTIBODIES AND METHODS OF USE

#3794
20120064548
2012-03-15

NOVEL GENES, COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY OF CERVICAL CANCER

#3795
20120064101
2012-03-15

Compounds and methods useful for detection and treatment of cancer

#3796
20120060239
2012-03-08

Method for secretory production of glycoprotein having human-type sugar chain using plant cell

#3797
20120060232
2012-03-08

Caveolin 1-reporter protein knock-in mouse

#3798
20120058933
2012-03-08

Synthetic peptides and peptide mimetics

#3799
20120058901
2012-03-08

ASSAY FOR THE DETECTION OF RECURRENCE IN BREAST CANCER USING THE NOVEL TUMOR SUPPRESSOR DEAR1

#3800
20120053232
2012-03-01

Isolated genomic polynucleotide fragments from the p15 region of isolated genomic polynucleotide fragments from the p15 region of chromosome 11 encoding human tumor suppressing subtransferable candidate 4 (TSSC4)

#3801
20120053129
2012-03-01

Target-activated cell/tissue-penetrating peptide for delivery of impermeable compounds and use thereof

#3802
20120053113
2012-03-01

Manufacture of inter-alpha-inhibitor (IaIp) from plasma

#3803
20120052530
2012-03-01

Combinatorial DNA library for producing modified -glycans in lower eukaryotes

#3804
20120052075
2012-03-01

Modulation of the Vps10p-domain receptor family for the treatment of mental and behavioural disorders

#3805
20120046448
2012-02-23

Chlamydomonas intraflagellar transport 88 (IFT-88)

#3806
20120046444
2012-02-23

PEPTIDE NETWORKS

#3807
20120045777
2012-02-23

NOVEL GENES ENCODING PROTEINS HAVING PROGNOSTIC, DIAGNOSTIC, PREVENTIVE, THERAPEUTIC, AND OTHER USES

#3808
20120045762
2012-02-23

gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and arteriosclerosis

#3809
20120041180
2012-02-16

Modified Human Plasma Polypeptide or Fc Scaffolds and Their Uses

#3810
20120041176
2012-02-16

UCP4

#3811
20120040910
2012-02-16

Methods of preventing or treating brain diseases

#3812
20120040451
2012-02-16

MOLECULES ABLE TO MODULATE THE EXPRESSION OF AT LEAST A GENE INVOLVED IN DEGRADATIVE PATHWAYS AND USES THEREOF

#3813
20120039919
2012-02-16

DIABETES DIAGNOSTIC, PROPHYLACTIC, AND THERAPEUTIC COMPOSITIONS AND METHODS

#3814
20120039914
2012-02-16

MIF antagonists

#3815
20120039912
2012-02-16

RSPONDIN-3 INHIBITION IN BONE DISORDERS

#3816
20120039889
2012-02-16

Methods of diagnosing and treating prostate cancer characterized by NDRG1-ERG fusion

#3817
20120039877
2012-02-16

E1-MINUS ADENOVIRUSES AND USE THEREOF

#3818
20120039806
2012-02-16

Compounds and Methods for Modulating an Immune Response

#3819
20120036590
2012-02-09

INTERFERON-LIKE PROTEIN ZCYTO21

#3820
20120035073
2012-02-09

COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES

#3821
20120034651
2012-02-09

Akt activity specifically inhibiting polypeptide

#3822
20120034188
2012-02-09

Akt Nucleic Acids, Polypeptides, and Uses Thereof

#3823
20120030779
2012-02-02

COMPOSITIONS AND METHODS FOR DETECTING, TREATING, OR PREVENTING REDUCTIVE STRESS

#3824
20120029169
2012-02-02

Methods and compositions comprising tau oligomers

#3825
20120028889
2012-02-02

INTEGRASE COFACTOR

#3826
20120028367
2012-02-02

Removing polypeptides from stool

#3827
20120028350
2012-02-02

Bone marrow targeting peptides

#3828
20120028266
2012-02-02

Discovery of candidate biomarkers of in vivo apoptosis by global profiling of caspase cleavage sites

#3829
20120028262
2012-02-02

GENES AND POLYPEPTIDES RELATING TO HUMAN PANCREATIC CANCERS

#3830
20120027677
2012-02-02

Prion-specific peptoid reagents

#3831
20120022237
2012-01-26

Antibody to SOST peptides

#3832
20120022128
2012-01-26

PKIB and NAALADL2 for Target Genes of Prostate Cancer Therapy and Diagnosis

#3833
20120021994
2012-01-26

Cancer antigen eEF2

#3834
20120021417
2012-01-26

DOPAMINERGIC NEURON PROLIFERATIVE PROGENITOR CELL MARKER Nato3

#3835
20120020990
2012-01-26

ISOLATED MAMMALIAN MONOCYTE CELL GENES; RELATED REAGENTS

#3836
20120020977
2012-01-26

Pancreatic cancer genes

#3837
20120016340
2012-01-19

COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER

#3838
20120016108
2012-01-19

Compositions and methods for treating kidney disease

#3839
20120016008
2012-01-19

Isolated genomic polynucleotide fragments from the p15 region of chromosome 11 encoding human ribosomal protein L26 (RIBO26)

#3840
20120016003
2012-01-19

POT1 alternative splicing variants

#3841
20120015884
2012-01-19

Polypeptides for Specific Targeting to Otx2 Target Cells

#3842
20120015877
2012-01-19

Isolated GDF trap polypeptide

#3843
20120015868
2012-01-19

Metastin derivatives and use thereof

#3844
20120015434
2012-01-19

EXPANSION OF NK CELLS AND THERAPEUTIC USES THEREOF

#3845
20120014998
2012-01-19

Modified chaperonin 10

#3846
20120014959
2012-01-19

Wise/Sost nucleic acid sequences and amino acid sequences

#3847
20120014942
2012-01-19

Method for the diagnosis and prognosis of malignant diseases

#3848
20120014876
2012-01-19

Antagonistic peptides for frizzled-1 and frizzled-2

#3849
20120010386
2012-01-12

Recombinant melusin fusion protein as pharmacological agent in the treatment of heart pathologies

#3850
20120010275
2012-01-12

Isolated genomic polynucleotide fragments from the p15 region of chromosome 11

#3851
20120010270
2012-01-12

Isolated genomic polynucleotide fragments from the p15 region of chromosome 11 encoding human tumor suppressing subtransferable candidate 6 (TSSC6)

#3852
20120010269
2012-01-12

Isolated genomic polynucleotide fragments from the p15 region of chromosome 11 encoding human SMS3

#3853
20120010268
2012-01-12

Isolated genomic polynucleotide fragments from the p15 region of chromosome 11 encoding human achaete-scute homolog 2 (HASH2)

#3854
20120010151
2012-01-12

Use of Wnt5-α peptide derivates for the treatment of melanoma and gastric cancer

#3855
20120009579
2012-01-12

Monocyte-derived nucleic acids and related compositions and methods

#3856
20120009190
2012-01-12

Pre-ligand assembly domain of the IL-17 receptor

#3857
20120004287
2012-01-05

THERAPEUTIC AGENT COMPRISING VASOHIBIN

#3858
20120003299
2012-01-05

Hsp9O-targeted anti-cancer chimeric peptide

#3859
20120003246
2012-01-05

Novel composition and methods for the treatment of psoriasis

#3860
20120003243
2012-01-05

YEAST ECTOPICALLY EXPRESSING ABNORMALLY PROCESSED PROTEINS AND USES THEREFOR

#3861
20120003220
2012-01-05

Nucleic acid molecules encoding B7-DC variants

#3862
20120003201
2012-01-05

VAULT AGENTS FOR CHRONIC KIDNEY DISEASE

#3863
20110319334
2011-12-29

Compositions and methods for treatment of neurodegenerative diseases

#3864
20110318367
2011-12-29

Targets for treatment of hypercholesterolemia

#3865
20110318284
2011-12-29

Sirtuin 6 activating peptides and cosmetic or pharmaceutical composition containing them

#3866
20110312514
2011-12-22

Method for determination and quantification of radiation or genotoxin exposure

#3867
20110312059
2011-12-22

TAU PROTEASE COMPOSITIONS AND METHODS

#3868
20110311543
2011-12-22

Tumor Antigens BFA5 for Prevention and/or Treatment of Cancer

#3869
20110311540
2011-12-22

WISP polypeptides and nucleic acids encoding same

#3870
20110311533
2011-12-22

REGULATION OF PROTEIN LEVEL

#3871
20110311526
2011-12-22

Antibodies that bind polypeptides involved in the process of bone remodeling

#3872
20110311450
2011-12-22

POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS

#3873
20110306559
2011-12-15

METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIC PAIN

#3874
20110306558
2011-12-15

PROSAPOSIN AS A NEUROTROPHIC FACTOR

#3875
20110306554
2011-12-15

PEPTIDE CAPABLE OF BINDING TO IMMUNOGLOBULIN

#3876
20110306044
2011-12-15

DELTA3, FTHMA-070, TANGO85, TANGO77, SPOIL, NEOKINE, TANGO129, AND INTEGRIN ALPHA SUBUNIT PROTEIN AND NUCLEIC ACID MOLECULES AND USES THEREOF

#3877
20110300558
2011-12-08

NANOPARTICLE FOR BIOAFFINITY ASSAYS

#3878
20110300160
2011-12-08

Antibodies specific for sulfated sclerostin

#3879
20110300159
2011-12-08

Sulfonated sclerostin, antibodies, epitopes and methods for identification and use therefor

#3880
20110300066
2011-12-08

Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, Autoimmune disease and other diseases

#3881
20110296544
2011-12-01

COLON CANCER TARGETS AND USES THEREOF

#3882
20110296539
2011-12-01

Mutant alpha-synuclein, and methods using same

#3883
20110294748
2011-12-01

Insulin-like growth factor 1 receptor binding peptides

#3884
20110294226
2011-12-01

Survival motor neurons (SMN) gene: a gene for spinal muscular atrophy

#3885
20110293707
2011-12-01

Use of the cathelicidin LL-37 and derivatives thereof for wound healing

#3886
20110293645
2011-12-01

WDRPUH epitope peptides and vaccines containing the same

#3887
20110293604
2011-12-01

POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN THE PROCESS OF BONE REMODELING

#3888
20110293579
2011-12-01

Bi-specific fusion proteins

#3889
20110293557
2011-12-01

CONJUGATES FOR THE ADMINISTRATION OF BIOLOGICALLY ACTIVE COMPOUNDS

#3890
20110293527
2011-12-01

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

#3891
20110288149
2011-11-24

Method of protecting against heart failure

#3892
20110288035
2011-11-24

PIMAP39 modulates LPS-induced inflammatory response

#3893
20110288034
2011-11-24

Methods of identifying adipocyte specific genes, the genes identified, and their uses

#3894
20110288031
2011-11-24

Identification of a novel BHD gene

#3895
20110288030
2011-11-24

Method of producing a paralytic peptide

#3896
20110288006
2011-11-24

Peptides and methods for inducing cell death

#3897
20110288002
2011-11-24

NOVEL BAG PROTEINS AND NUCLEIC ACID MOLECULES ENCODING THEM

#3898
20110287955
2011-11-24

POLYPEPTIDE MARKER FOR DIAGNOSIS OF ARTERIOSCLEROSIS, METHOD FOR DETECTION OF ARTERIOSCLEROSIS BY USING THE MAKER OR THE LIKE, AND KIT FOR DIAGNOSIS OF ARTERIOSCLEROSIS

#3899
20110287458
2011-11-24

METHOD AND COMPOSITION FOR THE DIAGNOSIS AND MONITORING OF INFLAMMATORY DISEASES

#3900
20110287442
2011-11-24

Tumor Antigen Protein, Gene, or Peptides from Topoisimerase 2 Alpha